Investment
Features
FeesSafety
Academy
More
Pluang+

Compare American Well Corp (AMWL) vs Crowdstrike Holdings Inc (CRWD) Price & Performance

American Well Corp
Crowdstrike Holdings Inc

Price performance

Price movement over the last 24 hours

Key statistics

American Well Corp vs Crowdstrike Holdings Inc — how do they compare? American Well Corp trades at $9.89 (market cap $165.58M), while Crowdstrike Holdings Inc trades at $187.4 (market cap $190.60B). The key difference: Crowdstrike Holdings Inc is far larger — about 1151.1× American Well Corp's market cap, and American Well Corp is trading nearer its 52-week high, Crowdstrike Holdings Inc nearer its low. Which is the better fit depends on your goals.

AMWLCRWD
Market Cap
$165.58M$190.60B
Sector
HealthTechnology
52-Week High
$9.91$199.38
52-Week Low
$3.78$87.56
Enterprise Value
-$9.66M$186.87B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

American Well Corp

AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.

While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.

Crowdstrike Holdings Inc

CrowdStrike (CRWD) trades at $187.18, down 5.66% in the last session, following its recent 4-for-1 stock split. The stock exhibits a bullish technical trend with strong moving average signals, though RSI levels suggest overbought conditions. Fundamentally, the company shows robust revenue growth, reaching $3.95 billion in 2025, and has beaten earnings estimates for three consecutive quarters. However, valuation multiples remain elevated with a P/E of 765.02, and net income margins are negative. Analyst sentiment is overwhelmingly positive, with 76% recommending a buy.

The outlook for CRWD is supported by strong demand in AI-driven cybersecurity, but high valuation and intense competition pose risks. Revenue growth acceleration and market leadership in zero-trust security present opportunities, though profitability challenges and premium pricing require careful monitoring. The consensus price target of $184.40 suggests limited near-term upside from current levels, indicating a balanced risk-reward profile for investors.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About American Well Corp

American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.

Read more on AMWL

About Crowdstrike Holdings Inc

CrowdStrike Holdings provides cybersecurity products and services aimed at protecting organizations from cyberthreats. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, identity protection, and log management. CrowdStrike went public in 2019 and serves customers worldwide.

Read more on CRWD